Avidity Biosciences's market cap is currently $7.17B. The company's EPS TTM is $-1.21; its P/E ratio is ―; Avidity Biosciences is scheduled to report earnings on August 7, 2025, and the estimated EPS forecast is $-1.09. See an overview of income statement, balance sheet, and cash flow financials.
